• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oncocyte Corporation - Common Stock (NQ:OCX)

3.200 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oncocyte Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024 ↗
August 08, 2024
OCX stock results show that OncoCyte beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via AB Newswire
News headline image
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
OncoCyte's Innovative Approach: Potential in Precision Diagnostics 
Via News Direct
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For... 
Via TheNewswire.com
News headline image
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024 ↗
May 15, 2024
OCX stock results show that OncoCyte missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
OncoCyte's Earnings: A Preview ↗
November 08, 2023
 
Via Benzinga
News headline image
Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
September 18, 2023
Via ACCESSWIRE
News headline image
Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
Via ACCESSWIRE
News headline image
Earnings Scheduled For May 12, 2025 ↗
May 12, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
April 01, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
March 26, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For March 24, 2025 ↗
March 24, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
November 12, 2024
 
Via Benzinga
News headline image
What to Expect from OncoCyte's Earnings ↗
November 11, 2024
 
Via Benzinga
News headline image
4 Analysts Assess OncoCyte: What You Need To Know ↗
May 16, 2024
 
Via Benzinga
News headline image
3 Penny Stocks That Insiders Are Buying
May 07, 2024
Penny stocks are a risky business but following the insiders to your next trade can alleviate some of the risks; these are the three hottest insider buys. 
Via MarketBeat
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
April 23, 2024
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
April 15, 2024
We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning! 
Via InvestorPlace
News headline image
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗
April 15, 2024
Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals. 
Via Benzinga
News headline image
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
April 15, 2024
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
April 12, 2024
 
Via Benzinga
News headline image
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023 ↗
April 12, 2024
OCX stock results show that OncoCyte missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Top 3 Health Care Stocks That May Collapse In Q2 ↗
April 12, 2024
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
April 12, 2024
Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning! 
Via InvestorPlace
News headline image
Earnings Scheduled For April 12, 2024 ↗
April 12, 2024
Companies Reporting Before The Bell • Progressive (NYSE:PGR) is projected to report quarterly earnings at $3.17 per share on revenue of $17.43 billion. 
Via Benzinga
News headline image
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket ↗
April 12, 2024
Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year 
Via Benzinga
News headline image
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
November 09, 2023
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
November 09, 2023
 
Via Benzinga
News headline image
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
October 25, 2023
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap